ContextVision AB is a medical technology company. It develops and sells image enhancement software for medical diagnosis and artificial intelligence. Its product portfolio includes image enhancement software for 2D/3D/4D (dimensional) ultrasound, magnetic resonance imaging (MRI), X-Ray, radiography, and mammography. its geographical segments are Asia, Europe, and America.
1983
40
LTM Revenue $14.1M
LTM EBITDA $4.8M
$32.9M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
ContextVision has a last 12-month revenue of $14.1M and a last 12-month EBITDA of $4.8M.
In the most recent fiscal year, ContextVision achieved revenue of $12.4M and an EBITDA of $3.8M.
ContextVision expects next 12-month revenue of XXX   and NTM EBITDA of XXX
See ContextVision valuation multiples based on analyst estimatesFY 2023 | FY 2024 | FY 2025 | LTM | NTM | |
---|---|---|---|---|---|
Revenue | $12.5M | $12.4M | XXX | XXX | XXX |
Gross Profit | $11.3M | $12.3M | XXX | XXX | XXX |
Gross Margin | 90% | 99% | XXX | XXX | XXX |
EBITDA | $4.8M | $3.8M | XXX | XXX | XXX |
EBITDA Margin | 38% | 31% | XXX | XXX | XXX |
Net Profit | $2.7M | $3.1M | XXX | XXX | XXX |
Net Margin | 22% | 25% | XXX | XXX | XXX |
Net Debt | n/a | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of April 15, 2025, ContextVision's stock price is NOK 5 (or $1).
ContextVision has current market cap of NOK 417M (or $39.4M), and EV of NOK 348M (or $32.9M).
See ContextVision trading valuation dataEV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
---|---|---|---|---|---|---|
$32.9M | $39.4M | XXX | XXX | XXX | XXX | $0.04 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Sign UpAs of April 15, 2025, ContextVision has market cap of $39.4M and EV of $32.9M.
ContextVision's trades at 2.4x LTM EV/Revenue multiple, and 7.3x LTM EBITDA.
Analysts estimate ContextVision's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See valuation multiples for ContextVision and 10K+ public compsFY 2024 | FY 2025E | FY 2026E | FY 2027E | |
---|---|---|---|---|
EV | $32.9M | XXX | XXX | XXX |
EV/Revenue | 2.7x | XXX | XXX | XXX |
EV/EBITDA | 8.6x | XXX | XXX | XXX |
P/E | 16.9x | XXX | XXX | XXX |
P/E/Growth | 4.2x | XXX | XXX | XXX |
EV/FCF | 11.9x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Sign UpContextVision's NTM/LTM revenue growth is 7%
ContextVision's revenue per employee for the last fiscal year averaged $0.3M, while opex per employee averaged $0.2M for the same period.
Over next 12 months, ContextVision's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .
Analysts estimate ContextVision's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See operational valuation multiples for ContextVision and other 10K+ public compsFY 2024 | NTM | FY 2025E | FY 2026E | FY 2027E | |
---|---|---|---|---|---|
Revenue Growth | -1% | XXX | XXX | XXX | XXX |
EBITDA Margin | 31% | XXX | XXX | XXX | XXX |
EBITDA Growth | -20% | XXX | XXX | XXX | XXX |
Rule of 40 (SaaS-only) | 37% | XXX | XXX | XXX | XXX |
Revenue per Employee | $0.3M | XXX | XXX | XXX | XXX |
Opex per Employee | $0.2M | XXX | XXX | XXX | XXX |
S&M Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
G&A Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
R&D Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
Opex to Revenue | 75% | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
EV/Revenue | EV/EBITDA | |||||
---|---|---|---|---|---|---|
2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
Australian Clinical Labs | XXX | XXX | XXX | XXX | XXX | XXX |
Clarity Pharmaceuticals | XXX | XXX | XXX | XXX | XXX | XXX |
CurveBeam AI | XXX | XXX | XXX | XXX | XXX | XXX |
Cyclopharm | XXX | XXX | XXX | XXX | XXX | XXX |
Healius | XXX | XXX | XXX | XXX | XXX | XXX |
XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
ContextVision acquired XXX companies to date.
Last acquisition by ContextVision was XXXXXXXX, XXXXX XXXXX XXXXXX . ContextVision acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiplesAcquired Company | EV | EV/Revenue | EV/EBITDA |
---|---|---|---|
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Sign UpWhen was ContextVision founded? | ContextVision was founded in 1983. |
Where is ContextVision headquartered? | ContextVision is headquartered in Norway. |
How many employees does ContextVision have? | As of today, ContextVision has 40 employees. |
Who is the CEO of ContextVision? | ContextVision's CEO is Mr. Gerald Potzsch. |
Is ContextVision publicy listed? | Yes, ContextVision is a public company listed on OSL. |
What is the stock symbol of ContextVision? | ContextVision trades under CONTX ticker. |
When did ContextVision go public? | ContextVision went public in 1997. |
Who are competitors of ContextVision? | Similar companies to ContextVision include e.g. Australian Clinical Labs, Clarity Pharmaceuticals, CurveBeam AI, Cyclopharm. |
What is the current market cap of ContextVision? | ContextVision's current market cap is $39.4M |
What is the current revenue of ContextVision? | ContextVision's last 12-month revenue is $14.1M. |
What is the current EBITDA of ContextVision? | ContextVision's last 12-month EBITDA is $4.8M. |
What is the current EV/Revenue multiple of ContextVision? | Current revenue multiple of ContextVision is 2.4x. |
What is the current EV/EBITDA multiple of ContextVision? | Current EBITDA multiple of ContextVision is 7.3x. |
What is the current revenue growth of ContextVision? | ContextVision revenue growth between 2023 and 2024 was -1%. |
Is ContextVision profitable? | Yes, ContextVision is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.